TRAVERSE Substudy Links Testosterone Therapy to Increased Fracture Risk in Older Men With Hypogonadism
A surprising outcome has emerged from the TRAVERSE study of testosterone replacement therapy in men with hypogonadism: an increased risk of fractures relative to placebo.